These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 24385910)

  • 1. Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1.
    Dutta S; Dlugosz LS; Drew DR; Ge X; Ababacar D; Rovira YI; Moch JK; Shi M; Long CA; Foley M; Beeson JG; Anders RF; Miura K; Haynes JD; Batchelor AH
    PLoS Pathog; 2013; 9(12):e1003840. PubMed ID: 24385910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the antigenic diversity of Plasmodium falciparum apical membrane antigen 1 and the requirements for a multi-allele vaccine against malaria.
    Drew DR; Hodder AN; Wilson DW; Foley M; Mueller I; Siba PM; Dent AE; Cowman AF; Beeson JG
    PLoS One; 2012; 7(12):e51023. PubMed ID: 23227229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis of antigenic escape of a malaria vaccine candidate.
    Dutta S; Lee SY; Batchelor AH; Lanar DE
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12488-93. PubMed ID: 17636123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and precise epitope mapping of monoclonal antibodies against Plasmodium falciparum AMA1 by combined phage display of fragments and random peptides.
    Coley AM; Campanale NV; Casey JL; Hodder AN; Crewther PE; Anders RF; Tilley LM; Foley M
    Protein Eng; 2001 Sep; 14(9):691-8. PubMed ID: 11707616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to polymorphic invasion-inhibitory and non-Inhibitory epitopes of Plasmodium falciparum apical membrane antigen 1 in human malaria.
    Mugyenyi CK; Elliott SR; McCallum FJ; Anders RF; Marsh K; Beeson JG
    PLoS One; 2013; 8(7):e68304. PubMed ID: 23861883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of immunodampening to overcome diversity in the malarial vaccine candidate apical membrane antigen 1.
    Harris KS; Adda CG; Khore M; Drew DR; Valentini-Gatt A; Fowkes FJ; Beeson JG; Dutta S; Anders RF; Foley M
    Infect Immun; 2014 Nov; 82(11):4707-17. PubMed ID: 25156737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A diversity-covering approach to immunization with Plasmodium falciparum apical membrane antigen 1 induces broader allelic recognition and growth inhibition responses in rabbits.
    Remarque EJ; Faber BW; Kocken CH; Thomas AW
    Infect Immun; 2008 Jun; 76(6):2660-70. PubMed ID: 18378635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide Display.
    Crossey E; Frietze K; Narum DL; Peabody DS; Chackerian B
    PLoS One; 2015; 10(7):e0132560. PubMed ID: 26147502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. posttranslational modification of recombinant Plasmodium falciparum apical membrane antigen 1: impact on functional immune responses to a malaria vaccine candidate.
    Giersing B; Miura K; Shimp R; Wang J; Zhou H; Orcutt A; Stowers A; Saul A; Miller LH; Long C; Singh S
    Infect Immun; 2005 Jul; 73(7):3963-70. PubMed ID: 15972483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and Characterisation of a Key Epitope in the Conserved C-Terminal Domain of the Malaria Vaccine Candidate MSP2.
    Seow J; Morales RA; MacRaild CA; Krishnarjuna B; McGowan S; Dingjan T; Jaipuria G; Rouet R; Wilde KL; Atreya HS; Richards JS; Anders RF; Christ D; Drinkwater N; Norton RS
    J Mol Biol; 2017 Mar; 429(6):836-846. PubMed ID: 28189425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive immunization with a multicomponent vaccine against conserved domains of apical membrane antigen 1 and 235-kilodalton rhoptry proteins protects mice against Plasmodium yoelii blood-stage challenge infection.
    Narum DL; Ogun SA; Batchelor AH; Holder AA
    Infect Immun; 2006 Oct; 74(10):5529-36. PubMed ID: 16988228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and light chain shuffling of a Plasmodium falciparum AMA1-specific human monoclonal antibody with growth inhibitory activity.
    Seidel-Greven M; Addai-Mensah O; Spiegel H; Chiegoua Dipah GN; Schmitz S; Breuer G; Frempong M; Reimann A; Klockenbring T; Fischer R; Barth S; Fendel R
    Malar J; 2021 Jan; 20(1):37. PubMed ID: 33430886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine mapping of an epitope recognized by an invasion-inhibitory monoclonal antibody on the malaria vaccine candidate apical membrane antigen 1.
    Collins CR; Withers-Martinez C; Bentley GA; Batchelor AH; Thomas AW; Blackman MJ
    J Biol Chem; 2007 Mar; 282(10):7431-41. PubMed ID: 17192270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications.
    Ouattara A; Takala-Harrison S; Thera MA; Coulibaly D; Niangaly A; Saye R; Tolo Y; Dutta S; Heppner DG; Soisson L; Diggs CL; Vekemans J; Cohen J; Blackwelder WC; Dube T; Laurens MB; Doumbo OK; Plowe CV
    J Infect Dis; 2013 Feb; 207(3):511-9. PubMed ID: 23204168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation.
    Igonet S; Vulliez-Le Normand B; Faure G; Riottot MM; Kocken CH; Thomas AW; Bentley GA
    J Mol Biol; 2007 Mar; 366(5):1523-37. PubMed ID: 17229439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of domain III of the blood-stage malaria vaccine candidate, Plasmodium falciparum apical membrane antigen 1 (AMA1).
    Nair M; Hinds MG; Coley AM; Hodder AN; Foley M; Anders RF; Norton RS
    J Mol Biol; 2002 Sep; 322(4):741-53. PubMed ID: 12270711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response.
    Kennedy MC; Wang J; Zhang Y; Miles AP; Chitsaz F; Saul A; Long CA; Miller LH; Stowers AW
    Infect Immun; 2002 Dec; 70(12):6948-60. PubMed ID: 12438374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The most polymorphic residue on Plasmodium falciparum apical membrane antigen 1 determines binding of an invasion-inhibitory antibody.
    Coley AM; Parisi K; Masciantonio R; Hoeck J; Casey JL; Murphy VJ; Harris KS; Batchelor AH; Anders RF; Foley M
    Infect Immun; 2006 May; 74(5):2628-36. PubMed ID: 16622199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited antigenic diversity of Plasmodium falciparum apical membrane antigen 1 supports the development of effective multi-allele vaccines.
    Terheggen U; Drew DR; Hodder AN; Cross NJ; Mugyenyi CK; Barry AE; Anders RF; Dutta S; Osier FH; Elliott SR; Senn N; Stanisic DI; Marsh K; Siba PM; Mueller I; Richards JS; Beeson JG
    BMC Med; 2014 Oct; 12():183. PubMed ID: 25319190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.